共 50 条
- [31] Nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD): the SENSCIS trial [J]. PNEUMOLOGIE, 2020, 74 : S57 - S58
- [32] Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression [J]. RMD OPEN, 2023, 9 (01):
- [36] Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial by Corticosteroid Use [J]. PNEUMOLOGIE, 2020, 74 : S59 - S61
- [37] Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (160): : na
- [38] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease [J]. Clinical Rheumatology, 2010, 29 : 1167 - 1168